Genus (GNS)

Up
Share Price:
2,162.00p
Market Cap:
£1,438.61m
Change Today:
2.00p
Sector:
Pharma and Biotech

Dividend Data

  30-Jun-2630-Jun-2530-Jun-2430-Jun-2330-Jun-22
Interim Dividend11.20p10.30p10.30p10.30p10.30p
Final Dividend24.00p21.70p21.70p21.70p21.70p
Total Dividend35.20p32.00p32.00p32.00p32.00p

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Jun-26 30-Jun-25 30-Jun-24 30-Jun-23 30-Jun-22
Continuing Operations          
Revenue 658.10 672.80 668.80 689.70 593.40
Operating Profit/(Loss) 87.30 42.40 6.40 40.50 49.40
Net Interest (15.80) (18.80) (18.30) (14.30) (6.20)
Profit Before Tax 310.50 28.50 5.50 39.40 48.40
Profit After Tax 285.50 19.30 2.40 31.80 36.70
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 285.50 19.30 2.40 31.80 36.70
Attributable to:          
Equity Holders of Parent Company 285.30 19.00 7.90 33.30 40.90
Minority Interests 0.20 n/a (5.50) (1.50) (4.20)
           
Total Dividend Paid cn/a cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year cn/a cn/a cn/a cn/a cn/a
           
Continuing EPS          
Earnings per Share - Basic 431.60p 29.30p 12.00p 50.80p 62.50p
Earnings per Share - Diluted 425.10p 28.90p 11.90p 50.50p 62.20p
Earnings per Share - Adjusted 110.30p 81.80p 65.50p 84.80p 82.70p
Continuing and Discontinued EPS          
Earnings per Share - Basic 431.60p 29.30p 12.00p 50.80p 62.50p
Earnings per Share - Diluted 425.10p 28.90p 11.90p 50.50p 62.20p
Earnings per Share - Adjusted 110.30p 81.80p 65.50p 84.80p 82.70p
           
Dividend per Share 35.20p 32.00p 32.00p 32.00p 32.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Jun-26 30-Jun-25 30-Jun-24 30-Jun-23 30-Jun-22
Assets          
Non-Current Assets          
Property, Plant & Equipment 353.90 379.30 438.30 164.40 171.40
Intangible Assets 152.90 158.10 175.70 174.00 183.00
Investment Properties n/a n/a n/a n/a n/a
Investments 208.60 66.00 61.60 62.30 41.20
Other Financial Assets n/a n/a 1.20 4.90 n/a
Other Non-Current Assets 43.30 41.20 39.90 342.90 364.80
  758.70 644.60 716.70 748.50 760.40
Current Assets          
Inventories 47.80 46.20 57.10 61.30 50.90
Trade & Other Receivables 120.90 119.20 135.20 136.10 133.50
Cash at Bank & in Hand 43.70 48.00 42.50 36.30 38.80
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 47.20 41.00 36.30 25.30 34.30
  259.60 254.40 271.10 259.00 257.50
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 1,018.30 899.00 987.80 1,007.50 1,017.90
           
Liabilities          
Current Liabilities          
Borrowings 4.30 2.90 18.90 14.20 7.10
Other Current Liabilities 112.90 128.40 131.70 133.00 144.20
  117.20 131.30 150.60 147.20 151.30
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 93.40 249.70 272.30 217.90 206.60
Provisions 27.50 26.10 34.10 61.50 72.30
Other Non-Current Liabilities 13.50 15.90 17.30 13.70 15.60
  134.40 291.70 323.70 293.10 294.50
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 251.60 423.00 474.30 440.30 445.80
           
Net Assets 766.70 476.00 513.50 567.20 572.10
           
Capital & Reserves          
Share Capital 6.70 6.60 6.60 6.60 6.60
Share Premium Account 179.10 179.10 179.10 179.10 179.10
Other Reserves (13.00) (31.20) 11.30 28.60 52.20
Retained Earnings 593.90 321.60 320.80 360.60 340.60
Shareholders Funds 766.70 476.10 517.80 574.90 578.50
           
Minority Interests/Other Equity n/a (0.10) (4.30) (7.70) (6.40)
Total Equity 766.70 476.00 513.50 567.20 572.10
Cash Flow 30-Jun-26 30-Jun-25 30-Jun-24 30-Jun-23 30-Jun-22
Net Cash Flow From Operating Activities 74.40 67.20 29.80 50.40 34.30
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities 97.80 (13.80) (19.30) (30.90) (67.20)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (178.00) (46.60) (2.80) (18.20) 21.90
Net Increase/Decrease In Cash (5.80) 6.80 7.70 1.30 (11.00)
Ratios - based on IFRS 30-Jun-26 30-Jun-25 30-Jun-24 30-Jun-23 30-Jun-22
Continuing Operations          
PE Ratio - Adjusted 19.5 25.0 25.2 25.5 30.3
PEG - Adjusted 0.6 1.0 n/a 12.8 n/a
Earnings per Share Growth - Adjusted 35% 25% -23% 2% -18%
Dividend Cover 3.13 2.56 2.05 2.65 2.58
Revenue per Share 989.02p 1,020.79p 1,018.18p 1,036.51p 907.41p
Pre-Tax Profit per Share 466.63p 43.24p 8.37p 59.21p 74.01p
Operating Margin 13.27% 6.30% 0.96% 5.87% 8.32%
Return on Capital Employed 44.15% 7.93% 3.59% 7.82% 8.09%
Continuing & Discontinued Operations          
PE Ratio - Adjusted 19.5 25.0 25.2 25.5 30.3
PEG - Adjusted 0.6 1.0 n/a 12.8 n/a
Earnings per Share Growth - Adjusted 35% 25% -23% 2% -18%
Dividend Cover 3.13 2.56 2.05 2.65 2.58
           
Dividend Yield 1.6% 1.6% 1.9% 1.5% 1.3%
Dividend per Share Growth 10.00% n/a n/a n/a n/a
Operating Cash Flow per Share 111.81p 101.96p 45.37p 75.74p 52.45p
Cash Incr/Decr per Share (8.72p) 10.32p 11.72p 1.95p (16.82p)
Net Asset Value per Share (exc. Intangibles) 922.44p 482.32p 514.26p 590.92p 595.00p
Net Gearing 7.04% 42.97% 48.03% 34.06% 30.23%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.